• Faster than qPCR. Simpler than NGS.

    Faster than qPCR. Simpler than NGS.

    nCounter®
    SPRINT
    Profiler

    Save $50K Today

  • transforming healthcare

    transforming healthcare

    FROM INSIGHT
    TO IMPACT

  • Small Sample. <strong>Big Insight.</strong>

    Small Sample. Big Insight.

    3D Biology™
    Technology

    Discover More

  • Expertly Curated. Ready to Use.

    Expertly Curated. Ready to Use.

    Gene Expression
    Panels

    Discover More

nCounter® Analysis System

More insights from 
less sample 

Download NEW nSolver 4.0 and
Advanced Analysis 2.0 updates!

Learn More

Companion Diagnostic Development

Right patient, right treatment, right time

Learn More

Prosigna® Breast Cancer Prognostic Gene Signature Assay

Empowering personalized treatment decisions
Learn More *See product pages for regulatory status information

FOCUSED

on actionable answers

nFORM BLOG

Q&A with Dr. David Coffey, FHCRC: Multi-analyte studies in multiple myeloma and lymphoma

David Coffey, MD, is a physician scientist with the Fred Hutchinson Cancer Research Center in Seattle, Washington. When he’s not treating patients, he’s in the lab researching blood cancers such as multiple myeloma and lymphoma. His research centers on the detection of circulating DNA in peripheral blood samples to identify mutations involved in these cancers. We recently spoke with Dr. Coffey about his research, the challenges he faces, and his vision for the future.

 
November 15, 2017

Read More

nCounter® Analysis in Complex Biology:

Gene expression profile predicts response to pembrolizumab

A video review of JCI publication by Ayers, et al:
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade

View Video

 

 

 

 

 

    PUBLICATIONS TO DATE

    View all Publications

    CAREERS

    Inspired to make the world a better place?
    We have just the place for you.

    Explore Opportunities